Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2016

Study Completion Date

February 28, 2019

Conditions
Glioblastoma
Interventions
DRUG

BKM120

PROCEDURE

Surgery

Surgery

Trial Locations (7)

10065

Memorial Sloan-Kettering Cancer Center, New York

77030

UT, MD Anderson Cancer Center, Houston

84112

Huntsman Cancer Institute, University of Utah, Salt Lake City

90095

University of California, Los Angeles, Los Angeles

94143

University of California, San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Memorial Sloan Kettering Cancer Center

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of Utah

OTHER

lead

Patrick Y. Wen, MD

OTHER